[CO2-laser therapy of stigmatizing cutaneous lesions in tuberous sclerosis (Bourneville-Pringle) and in neurofibromatosis 1 (von Recklinghausen)].
Tuberous sclerosis (Bourneville-Pringle) and type I neurofibromatosis (von Recklinghausen) are familial multiple tumour syndromes. Both entities have in common that the cutaneous manifestations can stigmatize the carriers and considerably reduce the quality of life. CO2-laser surgery (vaporisation) consistently yields good to excellent aesthetic results in the treatment of adenoma sebaceum in tuberous sclerosis. Patients with type I neurofibromatosis who carry several hundreds neurofibromas usually benefit from a numerical reduction in their skin lesions, despite the less predictable aesthetic result, ranging from excellent to fair. The present study reports on the treatment outcome of CO2-laser surgery in 8 patients with adenoma sebaceum and 8 with neurofibromatosis.
Querings
K
K
Dermatologische Klinik und Poliklinik, Universitätsspital Zürich.
Fuchs
D
D
Küng
E E
EE
Hafner
J
J
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D053685:Laser Therapy; D008297:Male; D009456:Neurofibromatosis 1 / Q000150:complications / Q000601:surgery*; D012189:Retrospective Studies; D012871:Skin Diseases / Q000601:surgery*; D014402:Tuberous Sclerosis / Q000150:complications / Q000601:surgery*